(Q35840548)

10 August 2017

0 references

Antiviral therapy in chronic hepatitis B viral infection during pregnancy: A systematic review and meta-analysis (English)

1 reference

10 August 2017

1 reference

1 reference

1 reference

1 reference

Robert S Brown

1

1 reference

10 August 2017

Brian J McMahon

2

1 reference

10 August 2017

Anna S F Lok

3

1 reference

10 August 2017

John B Wong

4

1 reference

10 August 2017

Ahmed T Ahmed

5

1 reference

10 August 2017

Mohamed A Mouchli

6

1 reference

10 August 2017

Zhen Wang

7

1 reference

10 August 2017

Larry J Prokop

8

1 reference

10 August 2017

Mohammad Hassan Murad

9

1 reference

10 August 2017

Khaled Mohammed

10

1 reference

10 August 2017

language of work or name

English

0 references

publication date

13 November 2015

1 reference

10 August 2017

1 reference

10 August 2017

volume

63

1 reference

10 August 2017

issue

1

1 reference

10 August 2017

page(s)

319-333

1 reference

Hepatitis B: global importance and need for control

10 August 2017

cites work

1 reference

Incidence of hepatitis B virus infections in preschool children in Taiwan.

21 January 2018

1 reference

The changing epidemiology of hepatitis B in the United States. Need for alternative vaccination strategies

21 January 2018

1 reference

Vertical Transmission of Hepatitis B Antigen in Taiwan

21 January 2018

1 reference

A longitudinal follow-up of asymptomatic hepatitis B surface antigen-positive chinese children

21 January 2018

1 reference

Age-specific prevalence and significance of hepatitis B e antigen and antibody in chronic hepatitis B virus infection in taiwan: A comparison among asymptomatic carriers, Chronic hepatitis, liver cirrhosis, and hepatocellular carcinoma

21 January 2018

1 reference

Perinatal hepatitis B virus transmission in the United States. Prevention by passive-active immunization

21 January 2018

1 reference

Outcome of perinatal hepatitis B virus exposure is dependent on maternal virus load

21 January 2018

1 reference

Effect of hepatitis B immunoglobulin on interruption of HBV intrauterine infection

21 January 2018

1 reference

Chronic hepatitis B: update 2009

21 January 2018

1 reference

Long-term monitoring shows hepatitis B virus resistance to entecavir in nucleoside-naïve patients is rare through 5 years of therapy

21 January 2018

1 reference

Long-term therapy with adefovir dipivoxil for HBeAg-negative chronic hepatitis B for up to 5 years

21 January 2018

1 reference

Long-term entecavir therapy results in the reversal of fibrosis/cirrhosis and continued histological improvement in patients with chronic hepatitis B.

21 January 2018

1 reference

Lamivudine in late pregnancy to interrupt in utero transmission of hepatitis B virus: a systematic review and meta-analysis

21 January 2018

1 reference

Hepatitis B virus and human immunodeficiency virus drugs in pregnancy: findings from the Antiretroviral Pregnancy Registry

21 January 2018

1 reference

How to read a systematic review and meta-analysis and apply the results to patient care: users' guides to the medical literature

21 January 2018

1 reference

Recommendations for examining and interpreting funnel plot asymmetry in meta-analyses of randomised controlled trials

21 January 2018

1 reference

A meta-analysis of lamivudine for interruption of mother-to-child transmission of hepatitis B virus

21 January 2018

1 reference

Lamivudine in late pregnancy to prevent perinatal transmission of hepatitis B virus infection: a multicentre, randomized, double-blind, placebo-controlled study.

21 January 2018

1 reference

Interruption of HBV intrauterine transmission: a clinical study

21 January 2018

1 reference

Telbivudine or lamivudine use in late pregnancy safely reduces perinatal transmission of hepatitis B virus in real-life practice

21 January 2018

1 reference

Efficacy and safety of tenofovir disoproxil fumarate in pregnancy to prevent perinatal transmission of hepatitis B virus.

21 January 2018

1 reference

Efficacy and safety of tenofovir disoproxil fumarate in pregnancy for the prevention of vertical transmission of HBV infection

21 January 2018

1 reference

The efficacy and safety of antiviral therapy with lamivudine to stop the vertical transmission of hepatitis B virus

21 January 2018

1 reference

A prospective and open-label study for the efficacy and safety of telbivudine in pregnancy for the prevention of perinatal transmission of hepatitis B virus infection

21 January 2018

1 reference

Efficacy of maternal tenofovir disoproxil fumarate in interrupting mother-to-infant transmission of hepatitis B virus

21 January 2018

1 reference

Comparison of telbivudine versus lamivudine in interrupting perinatal transmission of hepatitis B virus

21 January 2018

1 reference

Lower Newborn Bone Mineral Content Associated With Maternal Use of Tenofovir Disoproxil Fumarate During Pregnancy

21 January 2018

1 reference

Safety of tenofovir use during pregnancy: early growth outcomes in HIV-exposed uninfected infants

21 January 2018

1 reference

Long-term safety of lamivudine treatment in patients with chronic hepatitis B.

21 January 2018

1 reference

Three-year efficacy and safety of tenofovir disoproxil fumarate treatment for chronic hepatitis B.

21 January 2018

1 reference

Telbivudine During the Second and Third Trimester of Pregnancy Interrupts HBV Intrauterine Transmission: A Systematic Review and Meta-analysis

21 January 2018

1 reference

Spontaneous hepatitis B e antigen to antibody seroconversion and reversion in Chinese patients with chronic hepatitis B virus infection

21 January 2018

1 reference

Clearance of hepatitis B e antigen in patients with chronic hepatitis B and genotypes A, B, C, D, and F

21 January 2018

1 reference

7 January 2021

Virologic factors associated with failure to passive-active immunoprophylaxis in infants born to HBsAg-positive mothers

1 reference

7 January 2021

Long-term treatment with entecavir induces reversal of advanced fibrosis or cirrhosis in patients with chronic hepatitis B

1 reference

7 January 2021

Telbivudine prevents vertical transmission from HBeAg-positive women with chronic hepatitis B

1 reference

7 January 2021

AASLD guidelines for treatment of chronic hepatitis B.

1 reference

7 January 2021

Identifiers

DOI

10.1002/HEP.28302

1 reference

release_mlh7fxbwnjh6lku7c27crzakiy

10 August 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/mlh7fxbwnjh6lku7c27crzakiy

24 November 2022

mapped directly with Wikidata item

1 reference